Literature DB >> 8154023

Obviation of prereperfusion rinsing and decrease in preservation/reperfusion injury in liver transplantation by portal blood flushing.

S Emre1, M E Schwartz, E Mor, K Kishikawa, O Yagmur, N Thiese, P Sheiner, R M Jindal, S Chiodini, C M Miller.   

Abstract

Liver allografts are traditionally rinsed with cold lactated Ringer's (LR) prereperfusion to clear K(+)-rich preservation solution from the hepatic vasculature. LR has been shown, however, to be injurious to the graft. By restoring portal blood flow without rinsing and discarding the initial blood traversing the liver (PB flush), we sought to eliminate rinsing without inducing hyperkalemia. Between August 1988 and December 1992, 481 OLTx were performed in 412 pts. Four rinsing methods were used sequentially: group 1 (157 pts)--low-flow-rate cold LR rinse (500 ml, 100 ml/min via standard i.v. tubing at 100 cm H2O [LFLR]) during lower caval anastomosis; Group 2 (120 pts)--LFLR as in group 1, at reperfusion, 500 ml PB flush via IVC catheter; group 3 (66 pts)--high-flow-rate LR rinse (500 ml, 1 L/min using large-bore tubing with 100 cm H2O rinsing pressure [HFLR]), PB flush as in group 2; Group 4 (62 pts)--no LR rinse; PB flush as in groups 2 and 3. Poor early graft function (PEGF) was defined as peak ALT or AST > 2500 U or PT > 16 sec (on POD 2); PEGF causing re-OLTx or death within 14 days was called primary nonfunction (PNF). Group 1 and Group 3 had high PEGF rates. Group 4 had significantly less PEGF than Group 1, with a trend toward a significant difference from Group 3. In Group 1, 3 pts. had intraoperative hyperkalemic cardiac arrest; this did not occur when PB flush was performed. PB flush without prior rinsing optimizes graft function without risk of hyperkalemia. LR rinse, alone or followed by PB flush, is unnecessary and may be deleterious.

Entities:  

Mesh:

Year:  1994        PMID: 8154023     DOI: 10.1097/00007890-199403270-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.

Authors:  S Roayaie; P A Sheiner; S Emre; S Guy; M E Schwartz; P Boros; C M Miller
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

2.  The Impact of Implantation Time During Liver Transplantation on Outcome: A Eurotransplant Cohort Study.

Authors:  Ina Jochmans; Steffen Fieuws; Ineke Tieken; Undine Samuel; Jacques Pirenne
Journal:  Transplant Direct       Date:  2018-05-18

3.  Post-Reperfusion Syndrome in Liver Transplantation: Does a Caval Blood Flush Vent Help?

Authors:  William D Stoll; William R Hand; Kenneth D Chavin; Dodson H Felton; Beth O Wolf; Grayce P Davis; Norman R Harvey; Joseph R Whiteley; Robert A Mester; Eric D Bolin
Journal:  Ann Transplant       Date:  2019-12-13       Impact factor: 1.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.